🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Empagliflozin vs. dapagliflozin for CV & renal outcomes: is there a winner? A new comparative observational study just published #openaccess in #EHJPharmacotherapy 💊 bit.ly/45ZVisF Felice Gragnano Mattia Galli DoreenTan.CVPx European Society of Cardiology Journals European Society of Cardiology #SGLT2 #HF #CKD

Excellent work led by a great scientist & friend Francesco Bruno now up EHJ Editor-in-Chief 👉doi.org/10.1093/ehjcvp… Ovidio De Filippo Lorenz Räber, MD PhD Fabrizio D'Ascenzo Florian Wenzl CardioTomLuscher

In a new meta-analysis, #ticagrelor but not clopidogrel monotherapy was better than #DAPT for ischemic and bleeding events after ACS, as we saw in #SIDNEY3. Read more #EHJPharmacotherapy 💊 ✅ academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief Mattia Galli Davide Capodanno European Society of Cardiology Journals

There’s a new meta-analysis out in #EHJPharmacotherapy on P2Y12-I monotherapy with #ticagrelor or #clopidogrel after short #DAPT in ACS. Read more 👉 bit.ly/4c7G5ai Felice Gragnano Mattia Galli DoreenTan.CVPx Davide Capodanno European Society of Cardiology Journals

Can #PCSK9 inhibitors help patients live longer? Read more in #EHJPharmacotherapy👉 bit.ly/3LHA2yy Felice Gragnano Mattia Galli DoreenTan.CVPx European Society of Cardiology European Society of Cardiology Journals

#Ticagrelor 60 mg was just as effective as ticagrelor 90 mg for elderly patients undergoing #PCI. There’s new randomised evidence in #EHJPharmacotherapy 👉 bit.ly/3WuVf3D Felice Gragnano Mattia Galli Raffaele Piccolo Giovanni Esposito European Society of Cardiology Journals #P2Y12 #antiplatelettherapy

A new study in #EHJPharmacotherapy looks at how a single-pill strategy could benefit patients with #CVD Read more with #openaccess 👉bit.ly/4dhGus4 Felice Gragnano Mattia Galli DoreenTan.CVPx European Society of Cardiology European Society of Cardiology Journals #Cardiology #CardioEd

📌 Single pill approach for CV disease #EHJPharmacotherapy 💊 EHJ-CVP Editor-in-Chief 👨‍💼 European Society of Cardiology European Society of Cardiology Journals 📚

🏆 The search for the holy grail: balancing the risk of #thrombosis and #bleeding. Check out the expert perspective by EHJ-CVP Editor-in-Chief in the latest issue of #EHJPharmacotherapy! 💊 academic.oup.com/ehjcvp/article… European Society of Cardiology European Society of Cardiology Journals #Cardiology #CardioX #CardioEd #CardioTwitter

CYP2C19 genetic testing for guiding #Mavacamten therapy: a viewpoint in #EHJPharmacotherapy 💊 👉 academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief 👨‍💼 European Society of Cardiology European Society of Cardiology Journals 📚 #Cardiology #CardioTwitter

PRECISE-DAPT after #CABG 🩸 #EHJPharmacotherapy 💊 EHJ-CVP Editor-in-Chief 👨‍💼 European Society of Cardiology Journals European Society of Cardiology #Cardiology #CardioTwitter #CardioEd

🫀Managing #dyslipidemia in patients with #comorbidities: Chronic Kidney Disease 💊Find out more at #EHJPharmacotherapy ➡️ academic.oup.com/ehjcvp/advance… #CardioTwitter #Cardiology #kidney #escardio #lipids #ckd EHJ-CVP Editor-in-Chief Stefan Agewall Felice Gragnano Mattia Galli Juan Carlos Kaski

💊#P2Y12 inhibitor monotherapy after short #DAPT in ACS: A systematic review and meta-analysis More at #EHJPharmacotherapy ➡️ academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief Stefan Agewall Mattia Galli Felice Gragnano Davide Capodanno Marco Valgimigli European Society of Cardiology Journals #CardioTwitter #heart #ESCYoung

📢 #ESCCongress2024 is just around the corner! I'm thrilled to be part of the #Faculty and to chair two sessions on #pharmacotherapy and #antithrombotics. Join us tomorrow in #London to discuss the latest scientific advances and new evidence 🔥 European Society of Cardiology #esccongress2024 #ESC

Management of dyslipidemia in patients with comorbidities: an insightful review article by the ESC WG on Cardiovascular #Pharmacotherapy just published in #EHJPharmacotherapy 👉 bit.ly/4elh1hV EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli DoreenTan.CVPx Rocco Montone

#Betablockers on QoL and well-being in MI pts w/ preserved LV function—a #REDUCEAMI substudy 👎🏻 QoL and well-being were not significantly different between 👥 ✔️More at #EHJPharmacotherapy ➡️ academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief Stefan Agewall #CardioTwitter #ESCCongress

Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction. JACC in press. Available online 1 September 2024 #climate #cicero #CardiologyNews #ESC

An old truth was not true !

The risk of serious cardiac adverse drug reactions to COVID-19 vaccines is low European Heart Journal - Cardiovascular Pharmacotherapy, pvae063, doi.org/10.1093/ehjcvp… #CardiologyNews #vaccins #Covid |European Society of Cardiology

📌 #Antithrombotic therapy and body mass: A Consensus Statement of the #ESC Working Groups on Cardiovascular #Pharmacotherapy and #Thrombosis. Discover more in #EHJPharmacotherapy 💊 👉 academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief European Society of Cardiology European Society of Cardiology Journals #Cardiology #CardioTwitter